Bruker Corporation
Bruker Corporation (Nasdaq: BRKR) develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions used to study chemical, biological and industrial materials at microscopic, molecular and cellular levels. Its customers include academic and government research institutions,… From the company’s description.
In fiscal 2025, Bruker Corporation reported revenue of $3.44B, up 2.1% from fiscal 2024, and a net loss of $8.30M. Its operating margin was 2.0%, and operations generated $134.10M in cash. Over the twelve months to Jun 30, 2026, revenue was $3.50B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Bruker Corporation does
In the company’s own words
Bruker Corporation (Nasdaq: BRKR) develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions used to study chemical, biological and industrial materials at microscopic, molecular and cellular levels. Its customers include academic and government research institutions, pharmaceutical and biotechnology companies, hospitals, diagnostic and clinical laboratories, manufacturers and other industrial users. The company has four reportable segments: BSI BioSpin, which supplies magnetic resonance, preclinical imaging, automation and laboratory software; BSI CALID, which provides mass spectrometry, microbiology and infection diagnostics, molecular spectroscopy and detection systems; BSI NANO, which offers X-ray, microscopy, metrology, spatial biology and cellular analysis technologies; and Bruker Energy & Supercon Technologies, which makes superconducting materials and related research tools. Products support applications ranging from life science and drug discovery to clinical diagnostics, food safety, materials analysis and semiconductor manufacturing. The company’s technology platforms include magnetic resonance, mass spectrometry, chromatography, X-ray, microscopy, metrology and molecular spectroscopy. Its website is www.bruker.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- BILLERICA, MA
- Fiscal year end
- December
- CIK
- 1109354
- SIC
- 3826
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Bruker Corporation — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Bruker Corporation’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Bruker Corporation and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Bruker Corporation's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Bruker Corporation's last four quarterly filings that the numbers alone won't show?”